Showing results (351-360 of 358) with videos related to
Sort By:
Pageof 36
You have reached the last page of results.This site can display upto 358 results.
Journal of Medicinal Chemistry|April 26, 2016
The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 KinasePamela A Haile, Bartholomew J Votta, Robert W Marquis, et al.Health Technology Assessment (Winchester, England)|February 7, 2018
PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancerPaula Ghaneh, Robert Hanson, Andrew Titman, et al.ACS Medicinal Chemistry Letters|October 23, 2018
Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion ChannelPamela A Haile, Linda N Casillas, Michael J Bury, et al.ACS Medicinal Chemistry Letters|June 20, 2020
Correction to Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion ChannelPamela A Haile, Linda N Casillas, Michael J Bury, et al.Nature|May 31, 2019
Author Correction: Design of amidobenzimidazole STING receptor agonists with systemic activityJoshi M Ramanjulu, G Scott Pesiridis, Jingsong Yang, et al.Nature|November 9, 2018
Design of amidobenzimidazole STING receptor agonists with systemic activityJoshi M Ramanjulu, G Scott Pesiridis, Jingsong Yang, et al.The Oncologist|May 20, 2026
Refining Prognosis in Advanced Renal Cell Carcinoma: International Real-World Validation of the Meet-URO Score in First-Line Immunotherapy CombinationsSara Elena Rebuzzi, Aruni Ghose, Sarah Rudman, et al.Science (New York, N.Y.)|September 10, 2005
Deep Impact: observations from a worldwide Earth-based campaignK J Meech, N Ageorges, M F A'Hearn, et al.Pageof 36